Zusammenfassung
Die Epidemiologie des Hautkrebses ist in den letzten Dekaden eingehend untersucht worden. Ausschlaggebend dafür war die starke Zunahme der Inzidenz sowohl der epithelialen Hautkrebse als auch des malignen Melanoms. Für das maligne Melanom der Haut war mit der Zunahme der Inzidenz gleichzeitig eine Zunahme der Mortalität verbunden. Mit dieser Entwicklung traten das maligne Melanom der Haut und auch die epithelialen Hautkrebse aus dem Kreis der seltenen Entitäten in den Bereich derjenigen Neoplasien ein, die eine wichtige medizinische Bedeutung besitzen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Abel EA (1989) Cutaneous manifestations of immunosuppression in organ transplant recipients. J Am Acad Dermatol 21: 167–179
Albert VA, Koh HK, Geller AC, Miller DR, Prout MN, Lew RA (1990) Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society. J Am Acad Dermatol 23: 308–310
Angst E, Bisig B, Tschopp A, Sigg C, Schuler G, Gutzwiller F, Schnyder UW (1989) Die Melanommortalität in der Schweiz 1970–1986. Schweiz Med Wochenschr 119: 1591–1598
Anonymus (1992) Death rates of malignant melanoma among white men-United States, 1973–1988. MMWR 41: 20–22, 27
Anonymus (1995) Deaths from melanoma-United States, 1973–1992. MMWR 44: 337, 343–347
Armstrong BK (1988) Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? J Dermatol Surg Oncol 14: 835–849
Armstrong BK, de Klerk NH, Holman CD (1986) Etiology of common acquired melanocytic nevi: constitutional variables, sun exposure, and diet. J Natl Cancer Inst 77: 329–335
Armstrong BK, Kricker A (1993) How much melanoma is caused by sun exposure? Melanoma Res 3: 395–401
Armstrong BK, Kricker A (1994) Cutaneous melanoma. Cancer Surv 19–20: 219–240
Austin PF, Cruse CW, Lyman G, Schroer K, Glass F, Reinigen DS (1994) Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol 1: 487–494
Autier P, Dore JF, Lejeune F et al. (1994) Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. EORTC Melanoma Cooperative Group. Int J Cancer 58: 809–813
Autier P, Dore JF, Lejeune F et al. (1994) Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma. Results of an European Organization for Research and Treatment of Cancer (EORTC) case-control study in Belgium, France and Germany. The EORTC Malignant Melanoma Cooperative Group. Melanoma Res 4: 79–85
Autier P, Dore JF, Schifflers E et al. (1995) Melanoma and use of sunscreens: an Eortc case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group. Int J Cancer 61: 749–755
Autier P, Joarlette M, Lejeune F, Lienard D, Andre J, Achten G (1991) Cutaneous malignant melanoma and exposure to sunlamps and sunbeds: a descriptive study in Belgium. Melanoma Res 1: 69–74
Balch CM, Soong SJ, Milton GW et al. (1983) Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia. Cancer 52: 1748–1753
Battistutta D, Palmer J, Walters M, Walker G, Nancarrow D, Hayward N (1994) Incidence of familial melanoma and MLM2 gene. Lancet 344: 1607–1608
Bavinck JN, de Boer A, Vermeer BJ et al. (1993) Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 129: 242–249
Bavinck JN, Gissmann L, Claas FH et al. (1993) Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients. J Immunol 151: 1579–1586
Boyle J, MacKie RM, Briggs JD, Junor BJ, Aitchison TC (1984) Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1: 702–705
Bulliard JL, Raymond L, Levi F, Schuler G, Enderlin F, Pellaux S, Torhorst J (1992) Prevention of cutaneous melanoma: an epidemiological evaluation of the Swiss campaign. Rev Epidemiol Sante Publique 40: 431–438
Burton RC, Armstrong BK (1995) Current melanoma epidemic: a nonmetastasizing form of melanoma? World J Surg 19: 330–333
Burton RC, Coates MS, Hersey P et al. (1993) An analysis of a melanoma epidemic. Int J Cancer 55: 765–770
Büttner P, Garbe C, Bertz J et al. (1995) Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark’s level for prognostic classification. Cancer 75: 2499–2506
Carey WP Jr, Thompson CJ, Synnestvedt M, Guerry D 4th, Halpern A, Schultz D, Elder DE (1994) Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer 74: 3118–3125
Carli P, Borgognoni L, Biggeri A, Carli S, Reali UM, Giannotti B (1994) Incidence of cutaneous melanoma in the centre of Italy: anatomic site distribution, histologic types and thickness of tumour invasion in a registry based study. Melanoma Res 4: 385–390
Carmichael VE, Wilson KS (1992) Primary cutaneous malignant melanoma: experience of the British Columbia Cancer Agency from 1972 to 1981. Can J Surg 35: 589–597
Cavalieri R, Macchini V, Mostaccioli S et al. (1993) Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962–1991. Ann 1st Super Sanita 29: 469–472
Christie D, Robinson K, Gordon I, Bisby J (1991) A prospective study in the Australian petroleum industry. II. Incidence of cancer. Br J Ind Med 48: 511–514
Collins RJ (1984) Melanoma in the Chinese of Hong Kong. Emphasis on volar and subungual sites. Cancer 54: 1482–1488
De Guire L, Theriault G, Iturra H, Provencher S, Cyr D, Case BW (1988) Increased incidence of malignant melanoma of the skin in workers in a telecommunications industry. Br J Ind Med 45: 824–828
de Rooij MJ, Rampen FH, Schouten LJ, Neumann HA (1995) Skin cancer screening focusing on melanoma yields more selective attendance. Arch Dermatol 131: 422–425
Elder DE (1995) Skin cancer. Melanoma and other specific nonmelanoma skin cancers. Cancer 75: 245–256
Elwood JM, Gallagher RP (1983) Site distribution of malignant melanoma. Can Med Assoc J 128: 1400–1404
Elwood JM, Whitehead SM, Davison J, Stewart M, Galt M (1990) Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. Int J Epidemiol 19: 801–810
English DR, Heenan PJ, Holman CD et al. (1986) Melanoma in Western Australia 1975–76 to 1980–81: trends in demographic and pathological characteristics. Int J Cancer 37: 209–215
Fritz K, Ziegler H (1983) Beitrag des Saarländischen Krebsregisters zur Epidemiologie der Hauttumoren. Z Hautkr 58: 901–915
Gafa L, Filippazzo MG, Tumino R, Dardanoni G, Lanzarone F, Dardanoni L (1991) Risk factors of nonmelanoma skin cancer in Ragusa, Sicily: a case-control study. Cancer Causes Control 2: 395–399
Gallagher RP, Elwood JM, Threlfall WJ, Band PR, Spinelli JJ (1986) Occupation and risk of cutaneous melanoma. Am J Ind Med 9: 289–294
Gallagher RP, Elwood JM, Threlfall WJ, Spinelli JJ, Fincham S, Hill GB (1987) Socioeconomic status, sunlight exposure, and risk of malignant melanoma: the Western Canada Melanoma Study. J Natl Cancer Inst 79: 647–652
Gallagher RP, Elwood JM, Yang CP (1989) Is chronic sunlight exposure important in accounting for increases in melanoma incidence? Int J Cancer 44: 813–815
Gallagher RP, Hill GB, Bajdik CD, Coldman AJ, Fincham S, McLean DI, Threlfall WJ (1995) Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol 131: 164–169
Gallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, McLean DI, Threlfall WJ (1995) Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 131: 157–163
Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HK, Spinelli J J, Beagrie M (1990) Anatomic distribution of acquired melanocytic nevi in white children. A comparison with melanoma: the Vancouver Mole Study. Arch Dermatol 126: 466–471
Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HK, Spinelli JJ, Beagrie M (1990) Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. Arch Dermatol 126: 770–776
Garbe C (1992) Sonne und malignes Melanom. Hautarzt 43: 251–257
Garbe C, Bertz J, Orfanos CE (1986) Malignes Melanom: Zunahme von Inzidenz und Mortalität in der Bundesrepublik Deutschland. Z Hautkr 61: 1751–1764
Garbe C, Büttner P, Bertz J et al. (1995) Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer 75: 2492–2498
Garbe C, Büttner P, Bertz J et al. (1995) Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 75: 2484–2491
Garbe C, Büttner P, Ellwanger U et al. (1995) Das Zentralregister Malignes Melanom der Deutschen Dermatologischen Gesellschaft in den Jahren 1983–1993. Epidemiologische Entwicklungen und aktuelle therapeutische Versorgung des malignen Melanoms der Haut. Hautarzt 46: 683–692
Garbe C, Büttner P, Weiss J et al. (1994) Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 102: 700–705
Garbe C, Büttner P, Weiss J et al. (1994) Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 102: 695–699
Garbe C, Krüger S, Stadler R, Guggenmoos Holzmann I, Orfanos CE (1989) Markers and relative risk in a German population for developing malignant melanoma. Int J Dermatol 28: 517–523
Garbe C, Orfanos CE (1989) Epidemiologie des malignen Melanoms in der Bundesrepublik Deutschland im internationalen Vergleich. Onkologie 12: 253–262
Garbe C, Orfanos CE (1992) Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Res [Suppl] 2: 285–294
Garbe C, Thiess S, Nürnberger F, Ehlers G, Albrecht G, Lindlar F, Bertz J (1991) Incidence and mortality of malignant melanoma in Berlin (West) from 1980 to 1986. Acta Derm Venereol 71: 506–511
Garbe C, Weiss J, Krüger S et al. (1993) The German melanoma registry and environmental risk factors implied. Recent Results Cancer Res 128
Garbe C, Wiebelt H, Orfanos CE (1989) Change of epidemiological characteristics of malignant melanoma during the years 1962–1972 and 1983–1986 in the Federal Republic of Germany. Dermatologica 178: 131–135
Garland CF, Garland FC, Gorham ED (1992) Could sunscreens increase melanoma risk? Am J Public Health 82: 614–615
Garland CF, Garland FC, Gorham ED (1993) Rising trends in melanoma. An hypothesis concerning sunscreen effectiveness. Ann Epidemiol 3: 103–110
Glass AG, Hoover RN (1989) The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 262: 2097–2100
Goldstein AM, Tucker MA (1995) Genetic epidemiology of familial melanoma. Dermatol Clin 13: 605–612
Gong G, Whittemore AS, West D, Moore DH, 2d (1992) Cutaneous melanoma at Lawrence Livermore National Laboratory: comparison with rates in two San Francisco bay area counties. Cancer Causes Control 3: 191–197
Goodman KJ, Bible ML, London S, Mack TM (1995) Proportional melanoma incidence and occupation among white males in Los Angeles County (California, United States). Cancer Causes Control 6: 451–459
Goss BD, Forman D, Ansell PE, Bennett V, Swerdlow AJ, Bürge S, Ryan TJ (1990) The prevalence and characteristics of congenital pigmented lesions in newborn babies in Oxford. Paediatr Perinat Epidemiol 4: 448–457
Graham Brown RA, Osborne JE, London SP, Fletcher A, Shaw D, Williams B, Bowry V (1990) The initial effects on workload and outcome of a public education campaign on early diagnosis and treatment of malignant melanoma in Leicestershire. Br J Dermatol 122: 53–59
Green A (1992) A theory of site distribution of melanomas: Queensland, Australia. Cancer Causes Control 3: 513–516
Green A, MacLennan R, Youl P, Martin N (1993) Site distribution of cutaneous melanoma in Queensland. Int J Cancer 53: 232–236
Greene MH, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE, Fräser MC (1985) High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 102: 458–465
Grob JJ, Gouvernet J, Aymar D et al. (1990) Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 66: 387–395
Gutman M, Cnaan A, Inbar M, Shafir R, Chaitchik S, Rozin RR, Klausner JM (1991) Are malignant melanoma patients at higher risk for a second cancer? Cancer 68: 660–665
Gutman M, Inbar M, Klausner JM, Chaitchik S (1993) Malignant melanoma in different ethnic groups in Israel. Incidence and biologic behavior. Cancer 71: 2746–2750
Healy E, Collins P, Barnes L (1995) Nonmelanoma skin cancer in an Irish population: an appraisal of risk factors. Ir Med J 88: 58–59
Heenan PJ (1985) Cutaneous malignant melanoma in western Australia. Pathology 17: 321–327
Heenan PJ, English DR, Holman CD, Armstrong BK (1991) Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981. Cancer 68: 2079–2087
Helmrich SP, Rosenberg L, Kaufman DW, Miller DR, Schottenfeld D, Stolley PD, Shapiro S (1984) Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use. J Natl Cancer Inst 72: 617–620
Herd RM, Cooper EJ, Hunter JA, Mclaren K, Chetty U, Watson AC, Gollock J (1995) Cutaneous malignant melanoma. Publicity, screening clinics and survival-the Edinburgh experience 1982–90. Br J Dermatol 132: 563–570
Hersey P, Sillar RW, Howe CG et al. (1991) Factors related to the presentation of patients with thick primary melanomas. Med J Aust 154: 583–587
Herzfeld PM, Fitzgerald EF, Hwang SA, Stark A (1993) A case-control study of malignant melanoma of the trunk among white males in upstate New York. Cancer Detect Prev 17: 601–608
Hiatt RA, Krieger N, Sagebiel RW, Clark WH Jr, Mihm MC Jr (1993) Surveillance bias and the excess risk of malignant melanoma among employees of the Lawrence Liver more National Laboratory. Epidemiology 4: 43–47
Hoffmann K, Dirschka T, Schatz H, Segerling M, Tiemann T, Hoffmann A, Altmeyer P (1993) A local education campaign on early diagnosis of malignant melanoma. Eur J Epidemiol 9: 591–598
Holly EA (1986) Cutaneous melanoma and oral contraceptives: a review of case-control and cohort studies. Recent Results Cancer Res 102
Holly EA, Kelly JW, Shpall SN, Chiu SH (1987) Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 17: 459–468
Iscovich J, Andreev H, Steinitz R (1995) Incidence of cutaneous malignant melanoma in Israel, 1960–1989. Public Health Rev 23: 1–23
Jelfs PL, Giles G, Shugg D, Coates M, Durling G, Fitzgerald P, Ring I (1994) Cutaneous malignant melanoma in Australia, 1989. Med J Aust 161: 182–187
Jones ME, Shugg D, Dwyer T, Young B, Bonett A (1992) Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient. Med J Aust 157: 373–378
Jung HD (1988) Epidemiologie des malignen Melanoms in der Deutschen Demokratischen Republik. II. Mitteilung. Mortalität, Verhältnis Mortalität/Inzidenz, Üb erleb ensraten, Verlust an Arbeits jähren. Dermatol Monatsschr 174: 73–79.
Kaldor J, Shugg D, Young B, Dwyer T, Wang YG (1993) Non-melanoma skin cancer: ten years of cancer-registry-based surveillance. Int J Cancer 53: 886–891
Karakousis CP, Driscoll DL (1995) Prognostic parameters in localised melanoma: gender versus anatomical location. Eur J Cancer 31A: 320–324
Kelly JW, Holly EA, Shpall SN, Ahn DK (1989) The distribution of melanocytic naevi in melanoma patients and control- subjects. Australas J Dermatol 30: 1–8
Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE, Tate BJ (1994) Sunlight: a major factor associated with the development of melanocytic nevi in Australian 113. schoolchildren. J Am Acad Dermatol 30: 40–48
Khlat M, Vail A, Parkin M, Green A (1992) Mortality from melanoma in migrants to Australia: variation by 114. age at arrival and duration of stay. Am J Epidemiol 135: 1103–1113
Kirkpatrick CS, Lee JA, White E (1990) Melanoma risk 115. by age and socio-economic status. Int J Cancer 46: 1–4
Kirkpatrick CS, White E, Lee JA (1994) Case-control 116. study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am J Epidemiol 139: 869–880
Ko CB, Walton S, Keczkes K, Bury HP, Nicholson C (1994) The emerging epidemic of skin cancer. Br J Dermatol 130: 269–272
Koh HK, Caruso A, Gage I et al. (1990) Evaluation of melanoma/skin cancer screening in Massachusetts. Preliminary results. Cancer 65: 375–379.
Koh HK, Geller AC (1995) Melanoma control in the United States: current status. Recent Results Cancer Res 139
Kopf AW, Kripke ML, Stern RS (1984) Sun and malignant 119. melanoma. J Am Acad Dermatol 11: 674–684
Krüger S, Garbe C, Büttner P, Stadler R, Guggenmoos Holzmann I, Orfanos CE (1992) Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. 120. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol 26: 920–926.
Kukita A, Ishihara K (1989) Clinical features and distribution of malignant melanoma and pigmented nevi on the soles of the feet in Japan. J Invest Dermatol 92: 210S-213S.
Lee JA (1989) The relationship between malignant melanoma of skin and exposure to sunlight. Photochem Photobiol 50: 493–496.
Lee JA, Scotto J (1993) Melanoma: linked temporal and latitude changes in the United States. Cancer Causes Control 4: 413–418
Lee PY, Silverman MK, Rigel DS et al. (1992) Level of education and the risk of malignant melanoma. J Am 124. Acad Dermatol 26: 59–63
Leigh IM, Glover MT (1995) Skin cancer and warts in immunosuppressed renal transplant recipients. Recent Results Cancer Res 139 125.
Levi F, La Vecchia C, Te VC, Mezzanotte G (1988) Descriptive epidemiology of skin cancer in the Swiss Canton of Vaud. Int J Cancer 42: 811–816.
Lindegard B (1990) Mortality and fatality of cutaneous malignant melanoma in Sweden, 1982–1986. Biomed Pharmacother 44: 495–501
Longstreth J (1988) Cutaneous malignant melanoma and 127. ultraviolet radiation: a review. Cancer Metastasis Rev 7: 321–333
Lyon JL, Gardner K, Gress RE (1994) Cancer incidence 128. among Mormons and non-Mormons in Utah (United States) 1971–85. Cancer Causes Control 5: 149–156
Mack TM, Floderus B (1991) Malignant melanoma risk 129. by nativity, place of residence at diagnosis, and age at migration. Cancer Causes Control 2: 401–411
MacKie R, Hunter JA, Aitchison TC et al. (1992) Cutaneous malignant melanoma, Scotland, 1979–89. The Scottish Melanoma Group. Lancet 339: 971–975
MacKie RM, Freudenberger T, Aitchison TC (1989) Personal risk-factor chart for cutaneous melanoma. Lancet 2: 487–490
MacKie RM, Smyth JF, Soutar DS et al. (1985) Malignant melanoma in Scotland 1979–1983. Lancet 2: 859–863
MacKie RM, Watt D, Doherty V, Aitchison T (1991) Malignant melanoma occurring in those aged under 30 in the west of Scotland 1979–1986: a study of incidence, clinical features, pathological features and survival. Br J Dermatol 124: 560–564
MacLennan R, Green AC, McLeod GR, Martin NG (1992) Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 84: 1427–1432
Magnus K (1991) The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer. Int J Cancer 47: 12–19
Marks R (1995) An overview of skin cancers. Incidence and causation. Cancer 75: 607–612
Marks R, Jolley D, Dorevitch AP, Selwood TS (1989) The incidence of non-melanocytic skin cancers in an Australian population: results of a five-year prospective study. Med J Aust 150: 475–478
McCredie M, Coates M, Grulich A (1994) Cancer incidence in migrants to New South Wales (Australia) from the Middle East, 1972–91. Cancer Causes Control 5: 414–421
McLaughlin JK, Malker HS, Blot WJ, Ericsson JL, Gemne G, Fraumeni JF Jr (1988) Malignant melanoma in the printing industry. Am J Ind Med 13: 301–304
Melia J, Cooper EJ, Frost T et al. (1995) Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. II. Characteristics and incidence of melanoma. Br J Dermatol 132: 414–421
Nelemans PJ, Rampen FH, Groenendal H, Kiemeney LA, Ruiter DJ, Verbeek AL (1994) Swimming and the risk of cutaneous melanoma. Melanoma Res 4: 281–286
Newell GR, Sider JG, Bergfelt L, Kripke ML (1988) Incidence of cutaneous melanoma in the United States by histology with special reference to the face. Cancer Res 48: 5036–5041
Newton JN, Redburn J (1995) Incidence of melanoma in four English counties, 1989–92. Br Med J [Clin Res] 310: 502–503
Osterlind A, Hou Jensen K, Moller Jensen O (1988) Incidence of cutaneous malignant melanoma in Denmark 1978–1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer 58: 385–391
Palmer JR, Rosenberg L, Strom BL, Harlap S, Zauber AG, Warshauer ME, Shapiro S (1992) Oral contraceptive use and risk of cutaneous malignant melanoma. Cancer Causes Control 3: 547–554
Paul E, Pausch A, Bodeker RH (1989) Speed of growth of melanoma: statistical analysis of the average ages of patient groups. Pigment Cell Res 2: 475–477
Quaba AA, Wallace AF (1986) The incidence of malignant melanoma (0 to 15 years of age) arising in „large” congenital nevocellular nevi. Plast Reconstr Surg 78: 174–181
Rauh M, Paul E, Illig L (1987) Incidence of malignant melanoma in Central Hesse, Germany. Anticancer Res 7: 447–448
Rhodes AR (1995) Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer? Cancer 75: 613–636
Riou JP, Ariyan S, Brandow KR, Fielding LP (1995) The association between melanoma, lymphoma, and other primary neoplasms. Arch Surg 130: 1056–1061
Roberts DL (1990) Malignant melanoma in West Glamorgan-increasing incidence and improving prognosis, 1986–88. Clin Exp Dermatol 15: 406–409.
Roberts LK, Stanfield JW (1995) Suggestion that sunscreen use is a melanoma risk factor is based on inconclusive evidence. Melanoma Res 5: 377–379
Roush GC, McKay L, Holford TR (1992) A reversal in the 147. long-term increase in deaths attributable to malignant melanoma. Cancer 69: 1714–1720
Roush GC, Schymura MJ, Holford TR (1988) Patterns of 148. invasive melanoma in the Connecticut Tumor Registry. Is the long-term increase real? Cancer 61: 2586–2595
Schaart FM, Garbe C, Orfanos CE (1993) Ozonabnahme und Hautkrebs: Versuch einer Risikoabschatzung. Hautarzt 44: 63–68
Scotto J, Fears TR (1987) The association of solar ultraviolet and skin melanoma incidence among Caucasians in the United States. Cancer Invest 5: 275–283.
Sober AJ (1987) Solar exposure in the etiology of cutaneous melanoma. Photodermatol 4: 23–31
Stanganelli I, Raccagni AA, Baldassari L, Calista D, Serafini M, Bucchi L (1994) Analysis of Breslow tumor thickness distribution of skin melanoma in the Italian region of Romagna, 1986–1991. Tumori 80: 416–421
Stern RS (1992) Risks of cancer associated with long term exposure to PUVA in humans: current status-1991. Blood Cells 18: 91–97
Stevens NG, Liff JM, Weiss NS (1990) Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Int J Cancer 45: 691–693
Stidham KR, Johnson JL, Seigler HF (1994) Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of 154. gender in prognostic outcome. Arch Surg 129: 316–324
Stierner U, Augustsson A, Rosdahl I, Suurkula M (1992) Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case control study. Melanoma Res 1: 367–375
Storetvedt Heldaas S, Andersen AA, Langard S (1987) Incidence of cancer among vinyl chloride and polyvinyl 156. chloride workers: further evidence for an association with malignant melanoma. Br J Ind Med 44: 278–280
Swerdlow AJ, English JS, Qiao Z (1995) The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol 32: 595–599
Thorn M, Bergstrom R, Adami HO, Ringborg U (1990) Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960–1984. Am J Epidemiol 132: 1066–1077
Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO (1994) Trends in tumour characteristics and survival of malignant melanoma 1960–84: a population-based study in Sweden. Br J Cancer 70: 743–748
Tucker MA, Boice JD Jr, Hoffman DA (1985) Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935–82. Natl Cancer Inst Monogr 68: 161–189
Tucker MA, Misfeldt D, Coleman CN, Clark WH Jr, Rosenberg SA (1985) Cutaneous malignant melanoma after Hodgkin’s disease. Ann Intern Med 102: 37–41
Vagero D, Ringback G, Kiviranta H (1986) Melanoma and other tumors of the skin among office, other indoor and outdoor workers in Sweden 1961–1979. Br J Cancer 53: 507–512
Vagero D, Swerdlow AJ, Beral V (1990) Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden. Br J Ind Med 47: 317–324
Vitasa BC, Taylor HR, Strickland PT et al. (1990) Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 65: 2811–2817
Walter SD, Marrett LD, From L, Hertzman C, Shannon HS, Roy P (1990) The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol 131: 232–243
Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T (1996) Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer 73: 255–259
Weiss J, Garbe C, Bertz J et al. (1990) Risikofaktoren für die Entwicklung maligner Melanome in der Bundesrepublik Deutschland. Ergebnisse einer multizentrischen Fall-Kontroll-Studie. Hautarzt 41: 309–313
Westerdahl J, Olsson H, Ingvar C, Brandt L, Jonsson PE, Moller T (1992) Southern travelling habits with special reference to tumour site in Swedish melanoma patients. Anticancer Res 12: 1539–1542
Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N (1995) Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res 5: 59–65.
Westerdahl J, Olsson H, Masback A et al. (1994) Use of sunbeds or sunlamps and malignant melanoma in southern Sweden. Am J Epidemiol 140: 691–699
White E, Kirkpatrick CS, Lee JA (1994) Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure. Am J Epidemiol 139: 857–868
Zanetti R, Franceschi S, Rosso S, Colonna S, Bidoli E (1992) Cutaneous melanoma and sunburns in childhood in a southern European population. Eur J Cancer 28A: 1172–1176
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Garbe, C. (1997). Epidemiologie des Hautkrebses. In: Garbe, C., Dummer, R., Kaufmann, R., Tilgen, W. (eds) Dermatologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60622-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-60622-9_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64480-1
Online ISBN: 978-3-642-60622-9
eBook Packages: Springer Book Archive